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Abstract: There has been a dramatic rise in the prevalence of IgE-mediated food allergy 
over recent decades, particularly among infants and young children. The cause of this 
increase is unknown but one putative factor is a change in the composition, richness and 
balance of the microbiota that colonize the human gut during early infancy.  
The coevolution of the human gastrointestinal tract and commensal microbiota has resulted 
in a symbiotic relationship in which gut microbiota play a vital role in early life immune 
development and function, as well as maintenance of gut wall epithelial integrity.  
Since IgE mediated food allergy is associated with immune dysregulation and impaired gut 
epithelial integrity there is substantial interest in the potential link between gut microbiota 
and food allergy. Although the exact link between gut microbiota and food allergy is yet to 
be established in humans, recent experimental evidence suggests that specific patterns of 
gut microbiota colonization may influence the risk and manifestations of food allergy.  
An understanding of the relationship between gut microbiota and food allergy has the 
potential to inform both the prevention and treatment of food allergy. In this paper we 
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review the theory and evidence linking gut microbiota and IgE-mediated food allergy in 
early life. We then consider the implications and challenges for future research, including 
the techniques of measuring and analyzing gut microbiota, and the types of studies required 
to advance knowledge in the field. 
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1. Introduction 
Food allergy is one of the epidemics of the modern world. Over the last twenty years rates of 
potentially life threatening reactions to food (anaphylaxis) have steadily risen in the developed  
world [1]. Such increases have been documented in the United Kingdom, the United States of America 
(USA) and developed areas of Asia [2–4]. Concordantly, in Australia during the 1990’s and 2000’s 
admission rates for food induced anaphylaxis through the Emergency Departments increased threefold 
primarily in children less than five years old [5]. Indeed it has been demonstrated in recent years that 
as many as 8%–10% of one year old infants living in Melbourne Australia have challenge proven  
IgE-mediated food allergy [6]. In children the commonest reason for anaphylaxis admission is  
IgE-mediated food allergy [5] and the cause of this epidemic remains elusive.  
The original hygiene hypothesis by Strachan proposed that exposure to infection in early life 
through larger family sizes was protective against allergic disease [7]. Subsequently the hypothesis has 
been “revisited” through work on the potential association between nonpathogenic microbial 
experience, immune development and allergic disease [8,9]. Allergic disease is more prevalent in 
modern urbanized communities [1] suggesting factors in the modern lifestyle and environment have 
driven the increase in food allergy. An example is the strong association of early life farm exposure 
and lower levels of atopic sensitization. This association has been shown in several studies including 
the GABRIELA and PARSIFAL cohorts [10–12]. It appears this early life farm exposure effect is 
mediated predominantly by microbial experience as children on farms are exposed to diverse microbial 
environments. It is plausible that such early life exposure modifies the composition of the human 
microbiome which may explain the association between non-pathogenic microbial experience, immune 
development and allergic disease.  
Recent advances in the measurement and analysis of the human microbiome have led to a 
dramatically more detailed understanding of the scale and variation of the gut microbiome [13] and a 
growing appreciation of the potential importance of the human microbiome in health and disease [14]. 
Of specific relevance, it has been shown that gut microbiota have a profound effect on gut immune 
development, barrier function and response to food antigens [15,16]. The human microbiome project 
has provided vast information on the determinants of the gut microbiota including the opportunity to 
examine its influence on non-communicable disease processes. There are a range of factors in the 
modern environment that may be associated with changes to both the microbiome and risk of food 
allergy, such as mode of delivery, antibiotic exposure, infant feeding practices, farming environment 
and country of origin. 
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In this review, we explore the theoretical basis for a relationship between gut microbiota and  
IgE-mediated food allergy. We then assess the current evidence for the association between specific 
factors in the modern environment and both: (a) the composition of the gut microbiota and  
(b) IgE-mediated food allergy in children. Finally, we consider the opportunities and challenges for 
future research in this area, including a discussion of the various techniques available for measurement 
and analysis of gut microbiota, as well as the study designs that are required. 
2. The Theoretical Basis for a Relationship between Gut Microbiota Development and  
IgE-Mediated Food Allergy 
There is a strong theoretical basis for the hypothesis that the composition of the gut microbiome 
during early life may influence the risk of food allergy. IgE-mediated food allergy is characterized by 
allergic sensitization and subsequent clinical allergic reaction following antigen re-exposure through 
the gut. Sensitization is the process where allergen specific T and B cells recognize and respond to an 
allergen leading to production of allergen specific IgE antibodies. The state of sensitization may or 
may not be associated with clinical allergic reaction upon re-exposure. The factors that lead to 
sensitization are poorly understood. One possible mechanism is resistance to or escape from gastric 
acid or enzymatic digestion. Ingested dietary proteins are generally not presented to the  
Gut Associated Lymphoid Tissue (GALT) as a result of gastric acid or enzymatic digestion and an 
intact gut epithelial barrier. Previous experiments on mice have shown that antigens that have bypassed 
gastric acid digestion through intra-ileal delivery are immunogenic once absorbed whereas antigens 
that have undergone gastric acid digestion and subsequently are absorbed induce tolerance [17]. 
Another experiment showed that oral tolerance could be disrupted by feeding mice encapsulated 
antigens that avoided gastric acid and enzyme digestion [18]. Concordantly, many food allergens,  
such as egg and peanut, have been shown to be resistant to breakdown by gastric acid [19]. It has also 
been shown that defects in gut barrier function are associated with an increased risk of allergic 
sensitization [20]. The presence of sensitization does not always result in clinical allergy. Only 30%–55% 
of people who are sensitized to food allergens such as egg, milk or peanut are also allergic and will 
have an allergic reaction upon re-exposure [6]. The factors that determine whether or not an individual 
who is sensitized also manifests clinical allergy remain unknown. In allergic subjects, allergen-specific 
IgE is bound to the surface of mast cells via high affinity FcE receptors. On re-exposure, allergen binding 
to allergen-specific IgE results in crosslinking of surface bound IgE and this in turn stimulates mast 
cells to release preformed mediators and produce additional pro inflammatory mediators, which together 
lead to an allergic response. Disruption in early gut microbiota development may alter gut epithelial 
integrity, affect immune development and potentiate the allergic response. The theoretical basis for this 
process is discussed below. 
2.1. Development and Modification of the Gut Microbiome during Early Life 
The term gut microbiota describes the total population of bacteria in the gut; there are an estimated 
1013 to 1014 organisms present comprising at least 400 species of bacteria [21,22]. The gut microbiome 
contains more than 100 times the number of genes in the human genome. Phase 1 of the Human 
Microbiome Project has demonstrated the dramatic variation in the composition of gut microbiota, 
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both between individuals, and within individuals over time [13] and the implications of such variation 
are the subject of intense research activity. 
The co-evolution of humans and their commensal gut organisms has resulted in an elegant 
symbiosis in which gut microbiota play a crucial role in the development and maintenance of gut 
immune and barrier function [15]. If this relationship becomes unbalanced, pathological processes 
such as immune mediated bowel inflammation, or conversely, sepsis can occur where invasion by 
opportunistic bacteria may prove fatal to the host. Thus, in order to maintain an effective balance,  
the immune system has evolved a variety of mechanisms to provide benefits for both host and 
commensal organisms. For example, tolerance is the ability of the immune system to recognize a 
harmless antigen and actively suppress an inflammatory response. Given the immense antigenic load 
presented by gut microbiota, the maintenance of tolerance is crucial to avoid excessive inflammation. 
The process of immune tolerance is assisted by anatomical isolation of microbiota within the gut 
lumen [23]. Goblet cells in the epithelial wall produce a mucus barrier that impedes the microbiota 
from penetrating the inner epithelium [24]. In addition, epithelial cells also produce a range of 
antimicrobial proteins, belonging to the same family of proteins as defensins that have the capacity to 
kill bacteria by compromising bacterial cell wall integrity [25]. Furthermore, secretory IgA is produced 
by B cells induced in the GALT and secreted across the epithelial wall. Gut secretory IgA is thought to 
be involved in trapping bacteria in the mucus layer preventing pathological invasion [26], thereby 
maintaining the normal host-microbiota balance [27]. Secretory IgA may also play a role in oral 
tolerance through the binding of antigens in the gut and preventing systemic uptake of the  
antigen [28]. In this context it has been shown that in mice sensitized to -lactoglobulin (a protein in milk) 
intestinal IgA levels are depressed compared to those in mice tolerant to -lactoglobulin [29];  
and further, that food allergy rates are higher in children with IgA deficiency [30]. 
In concert with host factors described above and barrier function, the commensal bacteria 
occupying the gut are genetically programmed not to express factors that enable cell invasion. 
Consequently if commensal bacteria happen to invade the epithelium they are quickly phagocytosed by 
the host [31]. Pathogenic organisms that manage to evade these host barriers to invasion can cause 
infection. For example, Campylobacter jejuni and Salmonella, which may result in life threatening 
illnesses, have flagella that aid invasion and appear resistant to antimicrobial proteins, while other 
pathogenic organisms are able to downregulate factors that are microbicidal [32,33]. 
2.2. Host Influences on Microbiome Development 
The early life colonization of the gut by bacteria essential for normal immune development is 
affected by factors including mode of delivery, antibiotic exposure, dietary intake and developing vs. 
developed world lifestyle. In addition to environmental factors there is some evidence that host 
genotype may influence the pattern of gut colonization during early life, which in turn, may predispose 
to specific gene-environment interactions [34]. For example, in experimental models, inbred mice have 
more comparable gut microbiota profiles than outbred mice [35]. Concordantly, in a twin study 
conducted among children aged up to ten years, the fecal microbiota of identical twins, fraternal twins 
and unrelated individuals were compared [36]. The similarity of gut microbiota patterns was greatest 
among identical twins. However, a subsequent study among adult twins found no evidence of an 
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association between host genotype and the composition of the gut microbiome [37]. This may reflect 
difference in the relationship between genotype and the gut microbiome in children as compared to adults, 
but it may also reflect study differences. In particular, the study among children used temporal 
temperature gradient gel electrophoresis (TTGE) to characterize the gut microbiota, whereas the study 
among adults used pyrosequencing, which provides a far more detailed picture of the microbiome. 
2.3. The Impact of the Gut Microbiome on the Developing Immune System 
The role the gut microbiota plays in immune development and acquisition of tolerance has been 
explored in various immune studies on germ free mice. The mouse is a useful model as ninety nine 
percent of mouse genes are shared with humans and their gut microbiota is quite similar to the human 
gut microbiome [38]. Early experiments demonstrated that gut associated lymphoid tissue, comprising 
organized structures of lymphoid tissue such as Peyer’s patches are poorly developed or absent in germ 
free mice [39,40]. Subsequent work has shown that germ free mice have reduced numbers and function 
of (CD4+CD25+Foxp3+) Tregulatory (Treg) cells within the mesenteric lymph nodes and Peyer’s 
patches, likely representing induced Treg’s (iTreg), which play a key role in the induction of tolerance, 
providing a putative mechanism for failure of oral tolerance in such mice [41–43]. It has been 
demonstrated that introduction of Bacteroides fragilis into the lower gut of germ free mice can 
redevelop the GALT and induce tolerance but only if done in the neonatal period. The introduction of 
Bacteroides fragilis is associated with induction of Treg’s cells via IL-10 dependent mechanisms 
which may explain its role in tolerance induction [44]. 
Allergic disease is, at least in part, related to enhanced responses from Th2 cells [45].  
During pregnancy the Th1 immune response of the fetus is suppressed to prevent excessive response to 
maternal antigens, and as a result, at birth the infant is skewed toward a Th2 response to novel  
antigens [46]. Th2 cells produce IL-4, IL-5 and IL-13 which aid the development of allergic inflammation. 
Exposure to gut microbiota shifts this response to development of Th1 cells, which promotes immune 
tolerance and maintains a Th1/Th2 balance [44,47]. The gut microbiota is one of the environmental 
signals that promote T-cell maturation [48]. A recent study highlighted that a lack of Bacteroides 
colonization may be associated with a poor Th1 response [49]. The Th1/Th2 balance is not the sole 
mechanism to maintain immune tolerance, indeed increased numbers of Th1 cells may be associated 
with established allergic disease [50]. Germ free mice demonstrate a persistent Th2 skew as a result of 
absent intestinal microbiota. 
2.4. Experimental Evidence Specifically Linking the Gut Microbiota and Development of Food Allergy 
Further experimental work suggests the relationship between gut microbiota and the immune 
system is interdependent in developing and maintaining tolerance, thus avoiding development of food 
allergy. IL4ra gain of function mutant mice are particularly susceptible to allergic sensitization.  
In a recent study by Noval Rivas et al. IL4ra mice had altered gut microbiota prior to sensitization 
compared to allergy resistant mice [16]. The establishment of sensitization in the IL4ra mice was 
associated with an altered microbial signature suggesting immune influence on the gut microbiota. 
When gut microbiota from allergic mice was transferred to allergy resistant mice, food allergy could 
be induced in the previously resistant mice suggesting the microbiota could modify the immune 
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response. Finally when they transferred allergen specific Treg cells into the IL4ra mice the process 
induced tolerance and suppressed further sensitization attempts. This is consistent with work by 
Yamashita et al. that also showed that transfer of Treg cells from allergen tolerant mice into naïve 
mice suppressed subsequent attempts at food induced anaphylaxis [51].  
2.5. Direct Evidence that the Composition of the Gut Microbiome Influences the Risk of Allergic 
Disease in Humans 
Compared to the few studies on gut microbiota and food allergy, the relationship between gut 
microbiota and eczema has been extensively studied, and eczema and food allergy are strongly 
associated entities. Wang et al. demonstrated reduced gut microbial diversity at one week of age in 
infants who subsequently developed eczema by eighteen months of age [52]. This finding was 
reproduced in a prospective study of infants determined to be at high risk of allergic disease that 
showed gut microbial diversity was reduced in the first week of life in children who developed atopic 
eczema by one year of age [53]. The lack of diversity in both studies was determined using the 
molecular technique T-RFLP. Abramhasson et al. showed using 16S rRNA sequencing that gut 
microbial diversity was reduced at one month of age in infants who subsequently developed  
IgE-related eczema with Bacteroides species lower in infants with eczema [54]. In each of the three 
studies discussed above gut microbiota was analyzed at the age of one week or one month each 
demonstrating reduced microbial diversity prior to the onset of atopic disease, a recognised strength of 
the studies. In contrast a more recent study by Nylund et al., using DNA microarray as a method of 
analyzing the microbiota, found greater microbial diversity in infants with atopic eczema at 6 and 18 
months of age compared to healthy infants. They also found there were higher counts of the species 
Firmicutes such as Clostridium and less Bacteroides [55], contrasting with previous studies that 
showed a lack of Bacteroides was associated with reduced microbial diversity [54]. 
So far the evidence on the association between food allergy and gut microbiota is limited.  
A small Spanish prospective case-control study examined the fecal microbiota of infants at the point of 
diagnosis of IgE-mediated cow’s milk protein allergy (CMPA) and after 6 months treatment with 
extensively hydrolyzed formula. They were compared with non-allergic controls. At diagnosis there 
was no difference in the percentage of bacterial species present in the feces of CMPA infants and 
controls, but there was a higher overall bacterial count in the allergic infants. Six months post 
diagnosis the allergic infants had higher proportions of Lactobacilli and less Bifidobacteria compared 
to controls [56]. These results contrast with previous studies as the gut bacteria appeared to be more 
numerous in the CMPA infants compared to controls. However these results were limited as they were 
based on bacterial culture alone. 
Another study by Alderberth et al. found no significant association between development of  
IgE-mediated food sensitization, eczema and stage of fecal microbe colonization [57]. There have been 
no studies examining microbiota composition prior to the onset of food allergy or utilizing deep 
sequencing technology for microbiota analysis. 
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3. What is the Evidence that Specific Environmental Factors are Associated with both (a) the 
Composition of Gut Microbiota, and (b) Risk of Food Allergy? 
A variety of factors in the modern environment have been shown to influence the composition of 
the gut microbiome. These include mode of delivery, antibiotic exposure, infant feeding practices, 
farming environment and differences between the developed and developing world. The link with food 
allergy is substantially less clear (Table 1). 
Table 1. Summary of the associations between specific environmental factors and  
gut microbiota and food allergy (levels of evidence taken from NHMRC Evidence 
Hierarchy) [58]. 
Environmental Factors Affect Gut Microbiota Affect Food Allergy Risk 
Mode of Delivery 
Consistent 
Level 3 (2) Evidence 
[59–61] 
Conflicting 
Level 3 (3) Evidence 
[62–70] 
Antibiotic Exposure 
Consistent 
Level 4 Evidence 
[71,72] 
Limited  
Level 4 Evidence 
[66,68,69,73] 
Infant Feeding/Diet 
Strong 
Level 3(2) Evidence 
[59,60] 
Conflicting 
Level 4 Evidence 
[74] 
Farming Environment 
Limited 
Level 4 Evidence 
[75] 
No Evidence 
Developing vs. Developed World 
Consistent 
Level 3(2) Evidence 
[13,76] 
Limited 
Level 4 Evidence 
[77] 
3.1. Mode of Delivery 
Caesarean-section rates are higher in the developed world compared to the developing world.  
The USA has witnessed a dramatic increase in the proportion of infants who are delivered by 
Caesarean-section from 5% of births in 1970 to 31% of births in 2010 [78]. In Canada Caesarean-section 
rates are more than 25% of total births while in sub-Saharan Africa they range from 4.1% to  
16.8 % [60,79]. 
The fetal gut is believed to be essentially sterile [80] (although recent work has suggested that there 
may bacteria present in meconium of newborns [81]). In a vaginal birth the baby is colonized by 
maternal commensal bacteria from the maternal birth canal and gut [82], so the bacterial colonization 
pattern of the neonate resembles that of the maternal birth canal [49,83]. By six months of age 
anaerobic species dominate the gut flora, a period which coincides with solid food introduction in most 
populations [84]. By the age of 2 years the infant gut will have developed an adult type pattern but full 
development may take several more years [49]. Caesarean-section bypasses the birth canal and in 
elective sections membranes may only be broken at the time of surgery with the baby delivered 
through a sterile surface. The gut bacteria lacking in a baby delivered by Caesarean-section include 
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Bacteroides, E-shigella and E. coli [60] and the baby may have higher levels of Clostridium difficile [59]. 
In developing countries Enterobacteriae colonization in babies delivered by Caesarean-section tends 
not to be delayed though this is likely attributable to poorer hygiene standards [85]. The altered gut 
microbiota pattern associated with Caesarean section can last several years as a Finnish study in 2009 
showed lower levels of Clostridium in seven year old children delivered by cesarean section compared 
to those delivered vaginally [61]. 
The evidence for a direct link between Caesarean-section and food allergy is conflicting.  
A recent meta-analysis presented at the American Academy of Asthma Allergy and Immunology 
reported children born to atopic mothers by Caesarean-section were more likely to be sensitized to 
milk, egg or peanut at 2 years of age [62]. This association appeared to be independent of the mother’s 
allergy status. However the link with challenge or exposure proven food allergy was not investigated. 
Concordantly, several observational studies in Europe found a positive association for Caesarean-section 
and an increased risk of food allergy, especially cow’s milk allergy. In a number of studies the 
relationship between mode of delivery and risk of food allergy was stronger if the mother was  
atopic [63–67]. By contrast, in the only population based study to use challenge proven food allergy as 
the primary outcome, Koplin et al. found no evidence for an association between egg allergy and 
Caesarean-section in Australia [68]. Similarly, a retrospective study from the USA found no difference 
between mode of delivery and food allergy [69], and a recent Finnish study on children up to 4 years 
was unable to demonstrate an association between Caesarean-section and development of food  
allergy [70]. In summary, evidence for an association between mode of delivery and gut microbiota is 
not reproduced in the limited studies done investigating the association between mode of delivery and 
food allergy. 
3.2. Antibiotic Exposure 
There is strong evidence that early life exposure to antibiotics influences an infant’s gut microbiota. 
In the developed world up to 35% of mothers and their babies depending on hospital policy will 
receive intrapartum antibiotics [86]. Reasons include group B Streptococcus infection, maternal pyrexia 
during labor, postnatal sepsis or prematurity. The most frequent recipients of antibiotics are premature 
infants in the neonatal intensive care unit. In addition to being resident in a more hygienic environment 
than standard hospital wards premature infants are also more likely to have been delivered by 
Caesarean-section than term infants which may confound data. With a prolonged neonatal stay gut 
colonization may be delayed [87]. The preterm neonatal gut in infants delivered less than  
33 weeks gestation is dominated initially by coagulase negative Staphylococcus and Enterobacteriae [72]. 
Use of antibiotics have been associated with lower counts of Bifidobacterium in the neonatal gut 
within the first month of life [71]. 
The evidence regarding the association between exposure to antibiotics and risk of food allergy is 
again conflicting. A large Finnish study found that perinatal exposure to antibiotics in infants was 
associated with an increased risk of cow’s milk allergy, as defined by elevated serum specific IgE, 
positive skin prick test or open challenge test with disappearance of symptoms after cow’s milk 
elimination from diet [73]. In contrast, a retrospective USA study found no association between food 
allergy and peri-natal antibiotics [69]; the Australian Healthnuts study found no association between 
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antibiotic use and development of egg allergy [68]; and the Europrevail birth study found no 
association between maternal antibiotic use in pregnancy and the development of food allergy in 
infants [66]. Of note, prematurity itself does not appear to confer an increased risk of food allergy [88]. 
3.3. Infant Feeding Practices 
Infant feeding influences the composition of the gut microbiota. An infant may be breastfed, 
formula fed or experience a combination of the two. Adlerberth et al. have reviewed evidence 
indicating the gut microbiota pattern of a breastfed infant showed little difference compared to a 
formula fed infant [59]. It had been previously suggested that Lactobacilli and Bifidobacterium counts 
tend to be higher in breastfed babies but in most studies over the last 30 years no significant differences 
have been found. However in a recent small Canadian study of 24 infants Clostridium difficle  
levels were significantly lower in breastfed infants compared to the formula fed infants [60].  
Certain species of Clostridium are well recognized as pathological organisms in older children and 
adults but the significance of the Clostridium genus in neonates is unknown. In addition the infants 
who were formula fed had a more diverse gut microbiota compared to breastfed infants [60].  
Another small study looking at the gut metagenome in breastfed versus formula fed infants suggested 
breastmilk promotes a positive interaction between the mucosal immune system and the gut 
microbiome through intestinal gene expression [89]. Breastfeeding was also found to be associated 
with a more diverse gut microbiota. It has been suggested that small mass oligosaccharides found in 
human breast milk specifically promote the colonization of the gut with a “healthy microbiota”,  
such as Bifidobacterium [90]. The type of infant formula ingested may have an effect on the gut 
microbiota. A study of 18 infants with cow’s milk protein allergy compared a period of feeding with 
lactose free extensively hydrolyzed formula, to a period of feeding with lactose containing extensively 
hydrolyzed formula. The omission of lactose was associated with substantially lower fecal 
Bifidobacteria and Lactobacilli as well as reduced concentrations of fecal short chain fatty acids [91]. 
Another study evaluated the relationship between whey intake and gut microbiota colonization during 
early infancy by comparing fecal specimens from infants who were fed either high whey containing 
infant formula, low whey containing formula, or breastmilk. There was no difference in bifidobacterial 
counts between groups, however Clostridia was less prevalent in the breastfeeding group compared to 
the formula group [92]. Fluorescent in situ Hybridization (FISH) was the molecular technique used to 
analyze the microbiota in this study. 
Intake of complex carbohydrates during infancy also affects the composition of the gut microbiota. 
In a study of nineteen infants intake of a formula high in complex carbohydrates was associated with a 
higher concentration of butyric acid (a short chain fatty acid) in the feces compared to the comparison 
group [93]. In addition, intake of the formula high in complex carbohydrates was associated with 
elevated fecal secretory IgA levels supporting the influence of complex carbohydrates on gut 
microbiota composition as secretory IgA production is associated with the presence of Bifidobacterium 
in the gut [94].  
Allergy prevention is hypothesized to be associated with greater microbial diversity but previous 
studies have been unable to produce conclusive evidence that exclusive breastfeeding is protective 
against allergic disease [74]. Human breastmilk is a rich source of secretory IgA in early postnatal  
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life [95]. It has been shown that intake of secretory IgA in breastmilk in the first year of life may be 
associated with a reduced risk of atopic dermatitis [96]. It has also been shown in another trial that 
maternal avoidance of cow’s milk during breastfeeding was associated with a reduced level of  
-lactogloblulin specific IgA in the breastmilk and a higher rate of cow’s milk allergy in their 
offspring [97]. 
The relationship between infant feeding particularly breastfeeding and food allergy is difficult to 
disentangle as there are both ethical and feasibility barriers to conducting randomized trials.  
3.4. Farming Environment 
The “hygiene hypothesis” articulated by Strachan in the late 1980s proposed that exposure to 
infection in early life through larger family sizes was protective against allergic disease [7]. 
Subsequent work, however, suggests that, rather than infectious diseases per se, the early life microbial 
experience in general is a key determinate of immune development and risk of allergic disease.  
It would seem logical to assume that exposure to a less hygienic environment throughout childhood 
such as a farm would promote the acquisition of a more diverse human gut microbiota. However there 
is only circumstantial evidence to support this assumption. Indeed, one study in 2007 comparing 
children from several European countries found children from farming backgrounds had less gut 
microbial diversity compared to non-farming children from the same geographical area [75]. 
For allergy the most compelling evidence comes from studies demonstrating that farming 
environment is associated with a reduced risk of allergic disease and that most of this effect appears to 
be related to microbial exposure. For example, the European GABRIELA and PARSIFIL studies 
found that children raised in farming environments had decreased rates of allergic disease, and that 
around 90% of this effect could be attributed to microbial exposure, rather than other factors in the 
farming environment such as sun exposure [10–12]. This may, in part relate to higher and more 
efficient Treg cell numbers at birth among infants from farming environments [98]. 
Therefore, while the protective effect of farming environment has been shown for asthma and 
allergic sensitization, studies into the relationship between farming environment and risk of food 
allergy are both insufficient and conflicting.  
3.5. Developing vs. Developed World 
Birth in a higher income country is associated with delayed gut colonization, reduced microbial 
diversity [13] and reduced turnover of bacterial strains in the infant gut [76]. There are a range of 
factors that may be involved, including hygiene practices and diet [99]. Concordantly, birth in a high 
income country is associated with an increased risk of allergic disease [100]. Further, it has been 
observed that migration from a developing to a developed country is associated with an increased risk 
of allergic disease, but only if migration occurs during the first years of life [77]. In a recent Australian 
study it was found that migration from South East Asia to Australia was associated with an increased 
risk of eczema in the infants of the migrants [101].  
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4. Implications and Challenges for Future Studies  
4.1. Evaluating Gut Microbiota Composition 
The gut microbiota is a complex entity making it difficult to characterize in a meaningful way.  
Early attempts to characterize the gut microbiota used fecal culture-based techniques. However, less than 
30% of the total fecal bacteria are identifiable using culture based techniques [102] providing a limited 
picture. Recent advances in microbiota measurement technology now provide greater information on 
the breadth of microbiota present generating enormous amounts of information that allow comparison 
of overall patterns/signatures which may be more relevant and useful in understanding complex 
biological responses. Most approaches are based on analysis of 16S rRNA [103], a common component 
of bacterial ribosomes containing variable regions that can be used for phylogenetic identification.  
One of the first and simplest molecular techniques was the analysis of Terminal Restriction 
Fragment Length Polymorphisms (TRFLP), following digestion of 16S rRNA amplicons using 
restriction enzymes [104]. TRFLP analysis generates profiles in which more abundant groups of 
bacteria give higher peaks, and greater diversity results in a greater number of peaks. TRFLP, 
however, provides a relatively non-specific and blunt picture because it does not differentiate to the 
species level. 
More recently, phylogenetic microarrays, such as HITChip [105], have been developed to provide a 
semi-quantitative profile of species-specific extracted DNA or 16S rRNA amplicons that are 
fluorescently labeled [106]. Phylogenetic microarrays have the advantage over TRFLP techniques of 
providing phylogenetic identification. It is also a qualitative technique that can identify particular 
species, although cross hybridization can result in multiple probes hitting single targets [107].  
The main use of phylogenetic microarray is to compare microbial populations between different hosts. 
Sequencing is a DNA extraction based method that requires information from the full 16S rRNA 
gene to be successful. This can then be compared to a standardized gene database to allow evaluation 
of specific microbiota [108], although the approach has relatively high cost and low throughput. 
Next Generation Sequencing (NGS) has been developed as a lower cost method based on multiple 
sequencing of DNA templates. NGS utilizes massive parallel sequencing of partial 16S rRNA gene 
amplicons, and consequently can run at 2,000 times the rate of earlier sequencing techniques,  
enabling less abundant bacteria to be detected [102]. NGS is used mainly to compare differing 
microbiota populations. 
Metagenomics is the newest method used to measure gut microbiota. Metagenomics provides data 
regarding the function of the microbiota in addition to the genetic diversity, and was the technique 
used in the recent Human microbiome project. Metagenomics is achieved by random fragmenting of 
DNA which reconstructed to create a continuous sequence. This approach facilitates the recognition of 
microbial genes that enhance bacteria-host interactions [21].  
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4.2. Analysis of Gut Microbiota Data 
4.2.1. Microbial Diversity 
It is important to recognize that, rather than being a specific biological entity, “microbial diversity” 
is variably a constructed metric encompassing the relative abundance distribution of distinct types of 
organisms and bacterial families. Other terms used to describe microbial diversity are “richness” and 
“evenness”. For example, if a sample had a few dominant species present at similar levels it would be 
described as having low richness, and high evenness. Microbial diversity is a semi-quantitative measure, 
that can be used to make comparisons between individuals with and without a given exposure or 
outcome of interest. Differences in fecal microbial diversity have been linked to several human 
diseases [109]. Recent studies have shown that breastfeeding may be associated with less microbial 
diversity. This is an unexpected finding as breastfeeding is thought to be protective against allergy and 
allergy prevention is associated with greater microbial diversity, and previous studies had suggested 
that breastfeeding may promote gut microbial diversity [60,110].  
In order to make the comparison of the microbial diversity of different samples relevant 
mathematical models have been used to provide a quantitative measure. The Shannon index is a 
measure of entropy (biodiversity) of the sample and the uncertainty of the sampling outcome [111]. 
The other commonly used model, the Simpson diversity index is an examination of the probability that 
taking two readings from the same sample will produce an equivalent result [112]. Each produces a 
numerical value used to compare different samples. 
4.2.2. The Metabolic Signature 
An alternative or complementary approach to evaluating the relationship between the composition 
of gut microbiota and disease is to focus on the microbiota metabolites rather than the microbiota 
themselves. The potential advantages of focusing on the metabolic signature include the fact that a 
wide variety of organisms may exert their biological effect via a more finite group of metabolite-host 
interactions; and further, that the metabolic signature is reflective of both the composition of the gut 
microbiome and the substrate (i.e., diet) available to these organisms. For example, there is mounting 
interest in the relationship between dietary intake of fermentable fibers, the production of short chain 
fatty acids (SCFA), and risk of allergic disease [113]. 
The SCFA are produced by anaerobic bacteria including the Firmicutes species [114] and have been 
recognized as one of the most important gut microbiota products as they are involved in several gut 
functions that maintain a healthy state. These include immune and inflammatory responses.  
For example, GPR43 is protein receptor present on immune cells and colonic epithelium that binds 
SCFA’s. The SCFA acetate is the only known ligand of GPR43. In a mouse model, it was shown that 
clinical and histological evidence of colitis was reduced after introduction of dietary acetate,  
but this benefit was absent in GPR43 knockout strains [115]. A study in 2000 by Bottcher et al. 
showed that SCFA levels including butyric acid was lower in children with asthma, atopic dermatitis 
or food allergy [116]. Measurement of SCFA levels in stools including butyric acid may provide the 
metabolic signature to evaluate the gut microbiota in healthy and diseased states. 
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4.3. What Types of Studies are Required? 
The opportunity to employ newer techniques such as next generation sequencing to provide a more 
detailed analysis of the gut microbiota has led to a vast array of information available about the 
bacteria species that comprise the gut microbiome. There is now a clear need to grasp this opportunity 
through future studies that incorporate the longitudinal assembly of data regarding the determinants of 
gut microbiota composition and risk factors for food allergy. Collection of maternal stool prior to 
delivery and infant stool on regular occasions during the first years of life will add to this data 
collection. Previous studies have relied on either retrospective parent reported allergy or specific IgE to 
identify allergy status which has lacked objectiveness. Prospectively, determination of primarily food 
sensitization and subsequently challenge proven IgE-mediated food allergy status will provide an ideal 
cohort for gut microbiota analysis at an early life stage which has been lacking in previous studies. 
There are, however, important logistical and feasibility considerations for such studies.  
The ability to prospectively assemble a large cohort and retain the majority of participants throughout 
the study period is a major challenge. In addition the standardization, collection and storage of 
numerous biospecimens require dedicated trained staff and involves potentially high costs. 
The need for longitudinal studies determining the potential relationship between gut microbiota and 
food allergy is well established. In the event of a positive association the next steps are trials of 
intervention where there are already several promising approaches. These include dietary 
manipulation, direct supplementation with specific microbiota metabolic products (e.g., delivery of 
acetate or butyrate to the bowel), modification of determinants of microbiota composition  
(e.g., perinatal antibiotics for group B Streptococcus prophylaxis) and fecal transplant to humans.  
5. Conclusions 
Food allergy rates in children have rapidly increased in both the developed and developing world 
and the possible causes merit investigation. The microbiome that occupies the human gut and its role 
in health and disease has become the target of intense scrutiny in recent years and there is evidence of 
its importance in autoimmune disease, obesity and allergic disease in general. It has been demonstrated 
that in early life the gut microbiota influence immune development and balance of Treg cells which 
may increase the risk of food allergy. Environmental factors that may affect gut microbiota patterns in 
early life include obstetric interventions in pregnancy, antibiotic exposure, infant feeding practices and 
a modern westernized lifestyle. Epidemiological studies examining the influence of these factors on 
gut microbiota have yielded consistently strong evidence for positive associations. In parallel, studies 
examining the same factors and the risk of food allergy have revealed at best weak associations.  
While there has only been to date limited examination of the relationship between gut microbiota and 
food allergy in humans, several studies on gut microbiota and other allergic disease such as eczema 
have yielded positive associations. An altered pattern of gut microbiota colonization in the gut in the 
early life period may directly increase the risk of food allergy in children. Prospective longitudinal 
cohort studies that obtain biospecimens at regular intervals for analysis and provide robust outcomes 
such as challenge proven food allergy are required. Subsequently, knowledge of the relationship 
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between early life gut microbiota and allergic disease may facilitate development of novel prevention 
and treatment strategies. 
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